Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Typesort descending $ Amount Activity Investigator Unit Sponsor Date
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
A Phase 1 Study of Oral LY3410738 to Patients with Advanced Solid Tumors with IDH1 Mutations Contract $452,432.52 Clinical Trial Rachna Shroff Cancer Center Division Medpace 11/2020
A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors Contract $682,977.50 Clinical Trial Edward Gelmann Cancer Center Division Pharmacyclics Incorporated 04/2020
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness Contract $1,003,039.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Eli Lilly and Company 09/2020
Hydromechanical Cleansing With V.A.C. VERAFLO CLEANSE CHOICE Dressing and NPWTi-d vs. Collagenase Ointment in the Management of Full-Thickness Wounds (ACCELERATE Trial) Contract $352,206.00 Clinical Trial Patrick Bosarge COM Phx Surgery KCI USA, Incorporated 10/2020
Applied Research to Address the Coronavirus (COVID-19) Emerging Public Health Emergency Contract $10,000.00 Research Jefferey Burgess Community Environment & Policy Abt Associates 05/2020
Phase 3b Study for Evaluation of Efficacy and Nutritional Benefits of Pancrelipase in Patients with Exocrine Pancreatic Insufficiency due to Periampullary and Pancreatic Cancer Contract $122,409.40 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 01/2020
A Multicenter Platform Evaluating Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults Contract $665,000.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Social & Scientific Systems, Inc 12/2020
A Phase 3, Randomized, Study of Neoadjuvant and Adjuvant Nivolumab Plus NKTR-214, Versus Nivolumab Alone Versus Standard of Care in Participants with Muscle-Invasive Bladder Cancer (MIBC) Who Are.... Contract $418,725.38 Clinical Trial Edward Gelmann Cancer Center Division Bristol-Myers Squibb 11/2020
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus Disease (Covid Contract $503,260.68 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Pharmaceutical Research Associates 08/2020
Introducing Palliative Care (PC) within the Treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial. Contract $662,300.00 Clinical Trial Rohit Nathan COM Phx Internal Medicine Duke University 10/2020
COVID-19-C3PO: Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) Contract $1,222,500.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine University of Michigan 08/2020
Ojo Con Su Vision Pilot Program Contract $15,000.00 Other Sponsored Activity Jesus Gonzalez Fagoaga Public Hlth Pract & Trans Rsch CommunicateHealth, Inc. 06/2020
The MITRAL Trial (Mitral Implantation of TRAnscatheter VaLves is Native Mitral Stenosis) Contract $62,000.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Mayo Foundation for Medical Education and Research (Mayo Clinic) 01/2020
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study on the Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC) Contract $173,775.50 Clinical Trial Deepak Acharya Sarver Heart Center Windtree Therapeutics, Inc. 12/2020
In Vivo Screening of Candidate Therapeutic Antibodies in a Preclinical Swine Model of Acute Lung Injury Contract $50,379.00 Research Christian Bime Medicine Aqualung Therapeutics, Corp. 04/2020
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants with Relapsed or Refractory Multiple Myeloma Who Have Normal and Varying Degrees of ... Contract $205,152.00 Clinical Trial Krisstina Gowin Cancer Center Division IQVIA RDS Inc. 11/2020
CREON (Pancrelipase) Therapy for Subjects with Exocrine Pancreatic Insufficiency (EPI) due to Pancreatic Cancer: A Double-Blind, Randomized, Parallel Design with 2 Dose Cohorts of Pancrelipase... Contract $117,787.55 Clinical Trial Jen-Jung Pan COM Phx Internal Medicine AbbVie Incorporated 08/2020
PROTECTED TAVR: Stroke PROTECTion with SEntinel During Transcatheter Aortic Valve Replacement Contract $1,543,309.17 Clinical Trial Ashish Pershad COM Phx Internal Medicine Boston Scientific Corporation 10/2020
Tempe's BEST Project Contract $10,000.00 Other Sponsored Activity Wendy Parent-Johnson Family and Community Medicine City of Tempe, Arizona 06/2020
Evaluate the Clinical and Economic Outcomes of Performing PD-L1 Test as an In-Vitro Diagnostic (IVD) Vs. as a Laboratory Developed Test (LDT) to Select Patients with Non-Small Cell Lung Cancer (NSCLC) Contract $61,080.00 Research Jason Hurwitz HOPE Center Ventana Medical Systems, Inc. 07/2020
Inflammatory Bowel/Disease West Contract $10,000.00 Instruction Sasha Taleban Medicine Celgene Corporation 01/2020
A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patien Contract $406,077.84 Clinical Trial Setsuko Chambers Cancer Center Division GOG Foundation, Inc. 12/2020
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants with Relapsed or Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impa Contract $205,152.00 Clinical Trial Krisstina Gowin Cancer Center Division IQVIA RDS Inc. 11/2020
Biology and Longitudinal Epidemiology of COVID-19 Observational Study (BLUE CORAL) Cooperative Agreement $164,300.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Albert Einstein College of Medicine 11/2020

Pages